Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes

被引：0
|
作者：
Tianyuan Lu
Vincenzo Forgetta
Oriana H. Y. Yu
Lauren Mokry
Madeline Gregory
George Thanassoulis
Celia M. T. Greenwood
J. Brent Richards
机构：
[1] Lady Davis Institute for Medical Research,Centre for Clinical Epidemiology
[2] Jewish General Hospital,Quantitative Life Sciences Program
[3] McGill University,Division of Endocrinology
[4] Jewish General Hospital,Department of Medicine
[5] McGill University,Preventive and Genomic Cardiology
[6] McGill University Health Centre and Research Institute,Department of Human Genetics
[7] McGill University,Gerald Bronfman Department of Oncology
[8] McGill University,Department of Epidemiology, Biostatistics & Occupational Health
[9] McGill University,Department of Twin Research and Genetic Epidemiology
[10] King’s College London,undefined
[11] Jewish General Hospital,undefined
来源：
Cardiovascular Diabetology | / 19卷
关键词：
Atherosclerosis; Coronary heart disease; Polygenic risk scores; Risk factors; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes
    Li, Bo
    Luo, Yan-Rong
    Tian, Feng
    Chen, Yun-Dai
    Tian, Jin-Wen
    Ding, Yu
    Zhu, Mei
    Li, Jing-Wei
    Zhang, Ying-Qian
    Shi, Wei-Ming
    ATHEROSCLEROSIS, 2020, 300 : 10 - 18
  • [22] Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial
    Halmesvaara, Otto
    Vornanen, Marleena
    Kaaeriainen, Helena
    Perola, Markus
    Kristiansson, Kati
    Konttinen, Hanna
    FRONTIERS IN GENETICS, 2022, 13
  • [23] Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score
    Junyent, Mireia
    Zambon, Daniel
    Gilabert, Rosa
    Nunez, Isabel
    Cofan, Montserrat
    Ros, Emilio
    ATHEROSCLEROSIS, 2008, 196 (02) : 803 - 809
  • [24] Predictive nomogram for coronary heart disease in patients with type 2 diabetes mellitus
    Xiao, Shucai
    Dong, Youzheng
    Huang, Bin
    Jiang, Xinghua
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Coronary heart disease in Type 2 diabetes: mechanisms and comprehensive prevention strategies
    Wang, Yabin
    Yu, Qiujun
    Fan, Daiming
    Cao, Feng
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (08) : 1051 - 1060
  • [26] Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth
    McGill, HC
    McMahan, CA
    Zieske, AW
    Tracy, RE
    Malcom, GT
    Herderick, EE
    Strong, JP
    CIRCULATION, 2000, 102 (04) : 374 - 379
  • [27] TYPE 2 DIABETES MELLITUS IS ASSOCIATED WITH CAROTID ARTERY PLAQUES IN PATIENTS WITH PREMATURE CORONARY HEART DISEASE
    Gabriel Juarez-Rojas, J.
    Posadas-Romero, Carlos
    Martinez-Alvarado, Rocio
    Jorge-Galarza, Esteban
    Reyes-Barrera, Juan
    Gabriela Sanchez-Lozada, L.
    Torres-Tamayo, Margarita
    Medina-Urrutia, Aida X.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (06): : 301 - 309
  • [28] Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease
    Ndrepepa, Gjin
    Colleran, Roisin
    Kastrati, Adnan
    CLINICA CHIMICA ACTA, 2018, 476 : 130 - 138
  • [29] The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease
    Watanabe, Takuya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [30] A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes
    I. Shai
    M. B. Schulze
    J. E. Manson
    M. J. Stampfer
    N. Rifai
    F. B. Hu
    Diabetologia, 2005, 48 : 1469 - 1476
12345